NCT04305444 2025-01-08Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's LymphomasZhejiang DTRM BiopharmaPhase 2 Terminated55 enrolled
NCT03836768 2023-02-15BTK Inhibitor DTRMWXHS-12 in Mantle Cell LymphomaZhejiang DTRM BiopharmaPhase 1 Completed20 enrolled